Salivary glands and noradrenergic transmission in diabetic rats

Autonomic and Autacoid Pharmacology

Volumn 22, Issue 2, 2002, Pages 65-71

  Vatta, M S ^a   Hope, S I ^a   Prendes, G M ^a   Bianciotti, L G ^a   Elverdin, J C ^a   Fernandez, B E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; METHOXAMINE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MOUTH DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORADRENERGIC SYSTEM; PAROTID GLAND; PATHOPHYSIOLOGY; RAT; SALIVARY GLAND; SALIVATION; SUBMANDIBULAR GLAND; ANIMAL; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; SECRETION; WISTAR RAT;

ADRENERGIC AGONISTS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA; SALIVARY GLANDS;

EID: 0036557248     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-8673.2002.00243.x     Document Type: Article

References (32)

1. ANDERSON, R. (1993). In vivo secretory response of submandibular glands in streptozotocin-diabetic rats to sympathetic and parasympathetic nerve stimulation. Cell. Tissue Res., 274, 559-566.
2. BIANCIOTTI, L.G., ELVERDIN, J.C., VATTA, M.S., COLATERLLA, C. & FERNANDEZ, B.E. (1994). Atrial natriuretic factor enhances induced salivary secretion in the rat. Regul. Pept., 49, 195-202.
3. BLAKELY, R.D., DE FELICE, L.J. & HARTZELL, H.C. (1994). Molecular Physiology of norepinephrine and serotonin transporters. J. Exp. Biol., 196, 263-281.
4. CONNER, S., IRANPOUR, B. & MILLS, J. (1970). Alterations in parotid salivary flow in diabetes mellitus. Oral Surg. Oral Med. Oral Pathol., 30, 55-59.
5. CUTLER, L.S., PINNEY, H.E., CHRISTIAN, C. & RUSSOTTO, S.B. (1979). Ultrastructural studies of the rat submandibular gland in streptozotocin induced diabetes mellitus. Virchows Arch. (A), 382, 301-311.
6. DE FONZO, R.A. (1992). Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia, 35, 389-397.
7. EPSTEIN, M. (1997). Diabetes and hypertension: the bad companions. J. Hypert., 15 (Suppl. 2), S55-S62.
8. FIGLEWICZ, D.P., BENTSON, K. & OCRANT, I. (1993). The effect of insulin on norepinephrine uptake by PC12 cells. Brain Res. Bull., 32, 425-431.
9. FIGLEWICZ, D.P., BROT, M.D., MCCALL, A.L. & SZOT, P. (1996). Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res., 736, 54-60.
10. GARCIA-RUBI, E. & CALLES-ESCANDON, J. (1999). Insulin resistance and type 2 diabetes mellitus: its relationship with the beta 3-adrenergic receptor. Arch. Med. Res., 30, 459-464.
11. KAHN, B.B. (1998). Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance. Cell, 92, 593-596.
12. KAHN, B.B., VICENT, D. & DORIA, A. (1996). Genetics of noninsulin-dependent (type II) diabetes mellitus. Annu. Rev. Med., 47, 509-531.
13. KAUFMAN, S. (1995). Tyrosine hydroxylase. Adv. Enzymol. Relat. Areas Mol. Biol., 70, 103-220.
14. KIM, J., RUSKOVICH, E.A., THOMAS, P.T., UEDA, T., AGRANOFF, B.W. & GREENE, D.A. (1991). Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozotocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes, 40, 1545-1554.
15. KUMER, S.C. & VRANA, K.E. (1996). Intrincate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem., 67, 443-462.
16. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
17. MALLET, J. (1996). Catecholamines: from gene regulation to neuropchiatric disorders. Trends Neurol. Sci., 19, 191-196.
18. MURRAH, V.A. (1985). Diabetes mellitus and associated oral manifestations: a review. J. Oral Pathol., 14, 271-281.
19. PARK, D.H., PARK, H.S., JOH, T.H., ANWAR, M. & RUGGIERO, D. (1990). Strain differences between albino and pigmented rats in monoamine-synthesizing enzyme activities of brains, retina and adrenal gland. Brain Res., 508, 301-304.
20. PIERCE, G.N., MADDAFORD, T.G. & RUSSELL, J.C. (1997). Cardiovascular dysfunction in insulin-dependent and non-insulin-dependent animal models of diabetes mellitus. Can. J. Physiol. Pharmacol., 75, 343-350.
21. QUISSELL, D.O., WATSON, E. & DOWD. F.J. (1992). Signal transduction mechanisms involved in salivary gland regulated exocytosis. Crit. Rev. Oral Biol. Med., 3, 83-107.
22. +-ATPase activity in the pathogenesis of human diabetic neuropathy. J. Neurol. Sci., 120, 159-167.
23. SHELLENBERG, M.K. & GORDON, J.H. (1971). A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxy-tryptamine from discrete brain areas. Anal. Biochem., 39, 356-372.
24. SILBIGER, S.R., COHEN, A.J., FISHMAN, J.B. & STOFF, J.S. (1994). Defective glomerular α-adrenergic signal transmission in spontaneously diabetic rats. J. Lab. Clin. Med., 124, 249-254.
25. TAKAI, N., UCHIHASHI, K., YOSHIDA, Y. & KAKUDO, Y. (1983). Salivation and hystological damage of submandibular and sublingual glands in streptozotocin-induced diabetic rats. J. Osaka Dent. Univ., 17, 65-72.
26. 2+-dependent actin filament severing protein that controls cortical actin network dynamics during secretion. Neurochem. Res., 25, 133-144.
27. TRIFARO, J.M. & VITALE, M.L. (1993). Cytoskeleton dynamics during neurotransmitter release. Trends Neurol. Sci., 16, 466-472.
28. VATTA, M.S., PRESAS, M., BIANCIOTTI, L.G., ZARRABEITIA, V. & FERNANDEZ, B.E. (1996). B and C types natriuretic peptides modulate norepinephrine uptake and release in the rat hypothalamus. Regul. Pept., 65, 175-184.
29. VATTA, M.S., RODRIGUEZ-FERMEPIN, M., DURANTE, G., BIANCIOTTI, L.G. & FERNANDEZ, B.E. (1999). Atrial natriuretic factor inhibits norepinephrine biosynthesis and turnover in the rat hypothalamus. Regul. Pept., 85, 101-107.
30. WEIR, G.C., CLORE, E.T., ZMACHINSKI, C.J. & BONNER-WEIR, S. (1981). Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes, 30, 590-595.
31. ZHU, X. & EICHBERG, J. (1990). 1,2-Diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J. Neurochem., 55, 1087-1090.
32. ZHU, X. & EICHBERG, J. (1991). A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA, 87, 9818-9822.